Effect of alkylbenzenesulfonate as a vehicle for 4-nitroquinoline 1-oxide on gastric carcinogenesis in rats.
D000230:Adenocarcinoma / Q000139:chemically induced; D000284:Administration, Oral; D000818:Animals; D002273:Carcinogens / Q000008:administration & dosage; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced; D006391:Hemangioma / Q000139:chemically induced; D006394:Hemangiosarcoma / Q000139:chemically induced; D008297:Male; D009374:Neoplasms, Experimental / Q000139:chemically induced*; D010212:Papilloma / Q000139:chemically induced; D014677:Pharmaceutical Vehicles; D011804:Quinolines / Q000008:administration & dosage; D051381:Rats; D013274:Stomach Neoplasms / Q000139:chemically induced*; D013451:Sulfonic Acids / Q000494:pharmacology*; D013501:Surface-Active Agents / Q000494:pharmacology
D002273:Carcinogens; D014677:Pharmaceutical Vehicles; D011804:Quinolines; D013451:Sulfonic Acids; D013501:Surface-Active Agents